Target Price | JPY6,811.54 |
Price | JPY6,754.00 |
Potential |
0.85%
register free of charge
|
Number of Estimates | 13 |
13 Analysts have issued a price target Chugai Pharmaceutical 2025 .
The average Chugai Pharmaceutical target price is JPY6,811.54.
This is
0.85%
register free of charge
JPY8,500.00
25.85%
register free of charge
JPY4,500.00
33.37%
register free of charge
|
|
A rating was issued by 15 analysts: 8 Analysts recommend Chugai Pharmaceutical to buy, 6 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Chugai Pharmaceutical stock has an average upside potential 2025 of
0.85%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion JPY | 1,111.37 | 1,116.36 |
11.79% | 0.45% | |
EBITDA Margin | 40.26% | 47.28% |
10.29% | 17.44% | |
Net Margin | 29.29% | 32.81% |
1.48% | 12.02% |
13 Analysts have issued a sales forecast Chugai Pharmaceutical 2024 . The average Chugai Pharmaceutical sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Chugai Pharmaceutical EBITDA forecast 2024. The average Chugai Pharmaceutical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Chugai Pharmaceutical Analysts have issued a net profit forecast 2024. The average Chugai Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share JPY | 197.83 | 222.61 |
13.10% | 12.53% | |
P/E | 30.85 | |
EV/Sales | 9.40 |
7 Analysts have issued a Chugai Pharmaceutical forecast for earnings per share. The average Chugai Pharmaceutical <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Chugai Pharmaceutical stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Chugai Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.